Hewang Lee is a researcher in the Laboratory for Hypertension Research within the Division of Kidney Diseases and Hypertension, Department of Medicine, at The George Washington University School of Medicine and Health Sciences. He earned his Master’s and Doctoral degrees in Internal Medicine (Cardiovascular Diseases) from Shanghai Medical University and Beijing Medical University, respectively. He subsequently advanced his training in molecular and cellular biology in Martinsried, Germany, followed by visiting fellowships at the National Institutes of Health and Johns Hopkins University. His primary research investigates the regulation of blood pressure by renal dopamine receptors. In recent years, he has expanded his focus to the roles of macrophages in chronic kidney disease, as well as mitochondrial function in hypertension, atherosclerosis, and other chronic inflammatory diseases. A central goal of his current research is to elucidate how neuropeptides (specifically neuropeptide FF) in the kidney and autophagy in the vasculature regulate blood pressure. He is a professional member of the American Heart Association (AHA) and the American Physiological Society (APS). Additionally, he serves as an Early Career Editorial Board Member for Biomolecules and a Review Editor for Frontiers in Pharmacology.